Botox / Vistabel

Record type

Source-linked family profile

Recorded maker

AbbVie (Allergan Aesthetics)

Classification

Neuromodulator

Material identity

onabotulinumtoxinA

Snapshot date

14 August 2026

Manufacturer and category are catalogue fields. They are not, by themselves, a regulatory classification or verification of the exact marketed presentation.

Names and markets

Aliases in this profile

• Botox Cosmetic

  United States brand name

• Vistabel

  Brand name used in selected European markets

Alias grouping supports discovery. It does not claim that regional products, labels, units, formulations, or authorised uses are interchangeable.

Product names and regulatory context do not travel automatically between countries. Each row below is limited to its named source market.

• Vistabel

  Allergan · Neuromodulator

  →

1. Manufacturer

   1. Botox Cosmetic official site

   Allergan Aesthetics, an AbbVie company · United States

   Open source ↗

   Supports: Botox Cosmetic brand identity and United States product context.

2. Regulator

   2. VISTABEL 4 Allergan units / 0.1 ml — public medicine record and RCP

   French Public Medicines Database / ANSM · France

   Open source ↗

   Supports: The current French VISTABEL name, prescription status, authorisation record, presentation, and botulinum-toxin-type-A identity.

3. Approved label

   3. BOTOX Cosmetic — current United States drug label

   U.S. National Library of Medicine (DailyMed) · United States

   Open source ↗

   Supports: The current United States BOTOX Cosmetic identity, labeler, prescription-label context, and onabotulinumtoxinA naming.

1. 1

   Market-scoped names

   BOTOX Cosmetic and Vistabel are documented market-scoped brand identities in this discovery profile.

   Scope: Alias grouping only; no interchangeability of product, presentation, unit, label, or authorised use is claimed.

   Evidence: VISTABEL 4 Allergan units / 0.1 ml — public medicine record and RCPEvidence: BOTOX Cosmetic — current United States drug label
2. 2

   Material / active name

   The United States source names onabotulinumtoxinA; the French source names botulinum toxin type A.

   Scope: Source terminology is preserved by jurisdiction and is not used for dose conversion.

   Evidence: VISTABEL 4 Allergan units / 0.1 ml — public medicine record and RCPEvidence: BOTOX Cosmetic — current United States drug label

Use boundary

What this record does not establish

• Regulatory statusOnly within a source's named jurisdiction; family-profile review does not establish status elsewhere.
• Authenticity or supply chainA catalogue name cannot authenticate an individual box, lot, or seller.
• Clinical suitabilityNo product selection, patient assessment, dose, protocol, or injection technique is provided.
• Availability or equivalenceNames, formulations, units, and presentations can vary by market and over time.